Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Eroğlu, Imdat; Çelik Eroğlu, Burcu; Uyaroğlu, Oğuz Abdullah; Sain Güven, Gülay

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

The Anatolian Journal of Cardiology

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here? [Anatol J Cardiol]

Anatol J Cardiol. 2020; 24(1): 19-20 | DOI: 10.14744/AnatolJCardiol.2020.73232

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Imdat Eroğlu¹, Burcu Çelik Eroğlu¹, Oğuz Abdullah Uyaroğlu², Gülay Sain Güven²
¹Department of Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
²Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey

Keywords: COVID-19, Angiotensin receptor blockers, Angiotensin Enzyme Inhibitors, Statins, Heparin

Imdat Eroğlu, Burcu Çelik Eroğlu, Oğuz Abdullah Uyaroğlu, Gülay Sain Güven. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?. Anatol J Cardiol. 2020; 24(1): 19-20

Corresponding Author: Oğuz Abdullah Uyaroğlu, Türkiye
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar